Effects of chronic heparin administration on coronary vascular adaptation to hypertension and ventricular hypertrophy in sheep

Circulation

Volumn 100, Issue 9, 1999, Pages 981-987

  Flanagan, Michael F ^a,b,e   Aoyagi, Teruhiko ^b   Arnold, Lucy W ^b   Maute, Christine ^a   Fujii, Alan M ^b   Currier, Joseph ^b   Bergau, Dennis ^b   Warren, Henry B ^c   Rakusan, Karel ^d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Growth substances; Heparin; Hypertension; Hypertrophy; Microcirculation

Indexed keywords

HEPARIN;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE PERFUSION; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHEEP;

EID: 0033621071     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.9.981     Document Type: Article

References (30)

1. Flanagan MF, Aoyagi T, Currier J, Colan SD, Fujii AM. Effect of young age on coronary adaptation to left ventricular pressure overload hypertrophy in sheep. J Am Coll Cardiol. 1994;24:1786-1796.
2. Aoyagi T, Fujii AM, Flanagan MF, Currier JJ, Colan SD, Mirsky I. Myocardial function of immature and mature sheep with pressure overload hypertrophy. Am J Physiol. 1992;262(Heart Circ Physiol 31): H1036-H1048.
3. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation. 1992;86:38-46.
4. Rakusan K, Wicker P. Morphometry of the small arteries and arterioles in the rat heart: effects of chronic hypertension and exercise. Cardiovasc Res. 1990;24:278-284.
5. Flanagan MF, Aoyagi T, Arnold L, Takahashi T, Currier J, Warren H, Izumo S. Age, bFGF and coronary adaptations to left ventricular pressure overload hypertrophy. J Am Coll Cardiol. 1994;23:93A. Abstract.
6. Rakusan K, Turek Z. Protamine inhibits capillary formation in growing rat hearts. Circ Res. 1985;57:393-398.
7. Flanagan MF, Fujii AM, Colan SD, Flanagan RG, Lock JE. Myocardial angiogenesis and coronary perfusion in left ventricular pressure overload hypertrophy in the young lamb: inhibition with chronic protamine administration. Circ Res. 1991;68:1458-1470.
8. Flanagan MF. Therapeutic coronary angiogenesis. In: Rakusan K, guest ed. Coronary Angiogenesis. In: Bittar EE, series ed. Advances in Organ Biology. Greenwich, Conn: JAI Press; 1999;7:215-279.
9. Weissberg PL, Grainger DJ, Sanahan CM, Metcalfe JC. Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation. Cardiovasc Res. 1993;27:1191-1198.
10. Klagsbrun M. The affinity of fibroblast growth factors (FGFs) for heparin: FGF-heparan sulfate interactions in cells and extracellular matrix. Curr Opin Cell Biol. 1990;2:857-863.
11. Klagsbrun M, Baird A. A dual receptor system is required for basic fibroblast growth activity. Cell. 1991;67:229-231.
12. 165 with soluble and cell associated flk-1 receptors. J Biol Chem. 1994;269: 12456-12461.
13. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031-26037.
14. Yokokawa K, Mandal AK, Kohno M, Horio T, Murakawa K-I, Yasunari K, Takeda T. Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. Am J Physiol. 1992;263:R1035-R1041.
15. Piatti PM, Monti LD, Valsecchi G, Conti M, Nasser R, Guazzini B, Fochesato E, Phan CV, Pontiroli AE, Pozza G. Effects of low-dose heparin infusion on arterial endothelin-1 release in humans. Circulation. 1996;94:2703-2707.
16. Thompson RW, Orlidge A, D'Amore PA. Heparin and growth control of vascular cells. Ann NY Acad Sci. 1989;556:255-267.
17. Skaletz-Rorowski A, Schmidt A, Breihardt G, Buddecke E. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells. Arterioscler Thromb Vasc Biol. 1996;16:1063-1069.
18. Hassoun PM, Thompson BT, Hales CA. Partial reversal of hypoxic pulmonary hypertension by heparin. Am Rev Respir Dis. 1992;145: 193-196.
19. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin Invest. 1992;90:2044-2049.
20. Sellke FW, Wang SY, Harada K, Friedman M, Edelman ER, Grossman W, Simons M. Basic fibroblast growth factor enhances endothelium-dependent relaxation of the collateral-perfused porcine coronary microcirculation. Am J Physiol. 1994;267(Heart Circ Physiol 36): H1303-H1311.
21. Casscells W, Speir E, Sasse J, Klagsbrun M, Allen P, Lee M, Calvo B, Chiba M, Haggroth L, Folkman J, Epstein SE. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest. 1990;85:433-441.
22. Fujii AM, Aoyagi T, Flanagan MF, Takahashi T, Bennett-Guerrero E, Colan SD, Izumo S. Response of the hypertrophied left ventricle to tachycardia: importance of maturation. Am J Physiol. 1993;264(Heart Circ Physiol 33):H983-H993.
23. Starvi GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation. 1995;92:11-14.
24. Asahara T, Bauters C, Pastore C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 1995;92(suppl II):II-365-II-371.
25. Pepper MS. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 1997;8:21-43.
26. 1 with cardiovascular cells: implications for development and disease. Clin Exp Pharm Physiol. 1996;23:193-200.
27. Light JT, Bellan JA, Roberts P, Force SD, Chen I-L, Kerstein MD, Kadowitz PJ, McNamara DB. Heparin treatment enhances the recovery of neoendothelial acetylcholine-induced vascular relaxation after balloon catheter injury in the rabbit aorta. Circulation. 1993;88(suppl 2):II-413-II-419.
28. Meurice T, Bauters C, Auffray JL, Vallet B, Hamon M, Valero F, Van Belle E, Lablanche J-M, Bertrand ME. Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. Circulation. 1996;93:18-22.
29. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91: 2793-2801.
30. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991;266:11947-11954.